Bluerock Acquisition Corp. (BLRK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the period ending December 12, 2025. Bluerock Acquisition Corp., a Cayman Islands emerging growth company, reports the consummation of its Initial Public Offering (IPO) and a concurrent Private Placement. The Company is a special purpose acquisition company (SPAC) listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
- Gross Proceeds (IPO): $172,500,000 from the sale of 17,250,000 Units at $10.00 per Unit.
- Gross Proceeds (Private Placement): $4,500,000 from the sale of 4,500,000 Private Placement Warrants at $1.00 per warrant.
- Total Capital Raised: $177,000,000.
- Trust Account Funding: $172,500,000 deposited into a U.S.-based trust account.
- Deferred Underwriting Commission: Up to $7,350,000 included in the trust account proceeds.
- Warrant Exercise Price: $11.50 per share.
Material Changes
The filing represents the Company's initial public listing. There is no prior comparable period for revenue or operating profit as the Company was not previously public. The primary material change is the transition from a private entity to a public company with $172.5 million in liquid assets held in trust for potential business combinations.
Outlook, Risks, and Management Commentary
Management has completed the IPO and Private Placement as previously announced. The Company has issued an audited balance sheet as of December 12, 2025, reflecting these proceeds. As a SPAC, the Company's primary objective is to effect a merger or acquisition. The filing notes the existence of deferred underwriting commissions payable upon the completion of a business combination. No specific risks or contingencies beyond standard SPAC operational structures are detailed in this specific excerpt.
Investor Verification Checklist
- Verify the full terms of the underwriting agreement regarding the $7,350,000 deferred commission.
- Review the audited balance sheet (Exhibit 99.1) for exact cash balances and initial working capital.
- Confirm the redemption rights and warrant exercise conditions detailed in the prospectus.
- Monitor the Company's timeline for identifying a target business combination.